CEFUROXIME AXETIL tablet, film coated

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

CEFUROXIME AXETIL (UNII: Z49QDT0J8Z) (CEFUROXIME - UNII:O1R9FJ93ED)

Available from:

PD-Rx Pharmaceuticals, Inc.

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Cefuroxime axetil tablets, USP are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of Streptococcus pyogenes . Limitations of Use - The efficacy of cefuroxime axetil tablets, USP in the prevention of rheumatic fever was not established in clinical trials. - The efficacy of cefuroxime axetil tablets, USP in the treatment of penicillin-resistant strains of Streptococcus pyogenes has not been demonstrated in clinical trials. Cefuroxime axetil tablets, USP are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of Streptococcus   pneumoniae , Haemophilus influenzae (including β - lactamase-producing strains), Moraxella catarrhalis (including β - lac

Product summary:

Cefuroxime axetil tablets USP, 250 mg of cefuroxime as cefuroxime axetil, are white film-coated, round-shaped biconvex unscored tablets embossed with W921 on one side and plain on other side as follows: 4 Tablets/ Bottle                    NDC 55289-385-04 30 Tablets/ Bottle                    NDC 55289-385-30 Store at 20° - 25°C (68° - 77°F). Replace cap securely after each opening.

Authorization status:

Abbreviated New Drug Application

Summary of Product characteristics

CEFUROXIME AXETIL- CEFUROXIME AXETIL TABLET, FILM COATED
PD-RX PHARMACEUTICALS, INC.
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
CEFUROXIME AXETIL
TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR
CEFUROXIME AXETIL
TABLETS.
CEFUROXIME AXETIL TABLETS, FOR ORAL USE
INITIAL U.S. APPROVAL: 1987
RECENT MAJOR CHANGES
Indications and Usage, Acute Bacterial Exacerbations of Chronic
Bronchitis and Secondary Bacterial
Infections of Acute Bronchitis: Secondary Bacterial Infections of
Acute Bronchitis (1.4)-
Removed 11/2016
Dosage and Administration, Dosage for Cefuroxime Axetil Tablets:
Secondary Bacterial Infections of Acute
Bronchitis (2.2) -Removed 11/2016
INDICATIONS AND USAGE
Cefuroxime axetil is a cephalosporin antibacterial drug indicated for
the treatment of the following
infections due to susceptible bacteria: ( 1)
Pharyngitis/tonsillitis (adults and pediatric patients) ( 1.1)
Acute bacterial otitis media (pediatric patients) ( 1.2)
Acute bacterial maxillary sinusitis (adults and pediatric patients) (
1.3)
Acute bacterial exacerbations of chronic bronchitis (adults and
pediatric patients 13 years and older) (
1.4)
Uncomplicated skin and skin-structure infections (adults and pediatric
patients 13 years and older) (
1.5)
Uncomplicated urinary tract infections (adults and pediatric patients
13 years and older) ( 1.6)
Uncomplicated gonorrhea (adults and pediatric patients 13 years and
older) ( 1.7))
Early Lyme disease (adults and pediatric patients 13 years and older)
( 1.8)
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of cefuroxime axetil
tablets and other antibacterial drugs, cefuroxime axetil tablets
should be used only to treat or prevent
infections that are proven or strongly suspected to be caused by
bacteria.
DOSAGE AND ADMINISTRATION
Tablets and oral suspension are not bioequivalent and are therefore
not substitutable on a milligram-
per-milligram basis. ( 2.1)
Administer tablets with